Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap5.12B
Enterprise Value3.71B
P/E Ratio19.07
PEG Ratio4.26
Price/Sales Ratio4.21
Price/Book Ratio1.64
Enterprise/Revenue2.66
Enterprise/EBITDA7.28

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.29
Operating Margin0.32
AD

Management Effectiveness

Return On Assets0.07
Return On Equity0.09

Income Statement

Revenue1.05B
Revenue/Share2.39
Gross Profit653.4M
EBITDA311.67M
Net Income272.54M
Diluted EPS0.71

Balance Sheet

Total Cash2.17B
Total Cash/Share5.68
Total Debt2.39M
Total Debt/Equity0
Current Ratio6.85
Book Value Per Share8.16

Price History

52-Week Change-61.17
52-Week High20.28
52-Week Low7.01
Moving Average 50 Days7.63
Moving Average 200 Days10.19

Statistics

Average Volume611,869
Shares Outstanding595.26M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.36
Trailing Annual Dividend Yield2.7
Payout Ratio0.69
Last Split Factor5:2
Last Split DateApril 20, 2020
AD